Accoy Pharmaceuticals, Inc (aka: ACCOY™) is a clinical stage DTx technology company focused on pharmaceuticals with a clear path to profitability. It utilizes its broadly applicable patents pending DTx platform technologies, the ACCOY System™, to develop and commercialize NDA approved drugs that address significant unmet medical needs and will: 1) have improved drug/safety profiles, 2) deliver a better, measurable clinical outcome, and 3) save on the total cost of care.

OUR FIRST RESPONSIBILITY IS TO THE PATIENT

BEYOND THE DRUG

ACCOY represents a next generation pharmaceutical industry business model.  ACCOY is focused on selling a measurable clinical outcome, not just a drug.  This has required a unique combination of core competencies which position ACCOY beyond traditional pharmaceuticals, diagnostics, devices, software, systems, data (point of care), and support services business definitions/silos – however, commercialization does not require any changes to current pharmaceutical industry practices.